Australian research shows decrease in retinopathy
Local medical researchers have published results showing a dramatic drop in rates of retinopathy amongst teens who reached HbA1c targets.
More than 1,500 Sydney teenagers were studied over 20 years from 1990-2009, and the rate of retinopathy in those studied went from 53% to 12%. The researchers also found links between retinopathy and how long the patient has had type 1 diabetes, how old they were when diagnosed, HbA1C levels, as well as blood pressure and social class.
Over the period, use of multiple daily injections (MDI) and insulin pumps (continuous subcutaneous insulin infusion or CSII) increased from 17% to 88%, and median HbA1c decreased from 9.1% to 8.5%. When patients reached the recommended HbA1C target of 7.5%, they had a much lower chance of complications.
0 Comments 
The 2011 Walk to Cure Diabetes was an outstanding success with a record number of events taking place in 28 locations all over Australia. It was great to see so many new faces taking part this year, along with our regular Walkers who have supported the Walk for many years.
There are many reasons why people jump out of a plane. Some people jump when they reach a milestone, some jump as a team building activity and others jump to face their fear. Now you have the opportunity to 
The JDRF-funded Type 1 Diabetes Prevention Trial is a groundbreaking medical trial that aims to determine if the risk of getting type 1 diabetes can be eliminated by a nasal insulin vaccine. The trial is now into its fifth year and has screened over six thousand people in Australia and New Zealand to assess eligibility, with 58 eligible people now participating in the trial.
JDRF congratulates Gwennyth Baker on being a finalist for the 2012 Victorian Senior Australian of the Year award. 
To mark World Diabetes Day 2011, JDRF is renewing its call for recognition of the differences between type 1 and type 2 diabetes. We continue to support our community with up to date research news and information.
JDRF is fundraising for the holiday season, and here’s how you can help! By becoming part of 
For the first time ever in parallel experiments in both France and Italy, two participants with type 1 diabetes were able to control their diabetes using an artificial pancreas system in a real-life setting. Participants spent a night at a hotel and eating at a restaurant while using the device, and attained near-normal glucose levels. The research team used approved insulin pumps and continuous glucose monitors, which were controlled by a hand-held device and monitored by the investigators to ensure safety.
My name is Will and I was diagnosed with Type 1 diabetes fourteen years ago. I have always tried to live with diabetes as a lifestyle, not a disease. So when given the opportunity to climb Mt Kilimanjaro in Africa with a group of twenty other trekkers, I accepted without hesitation.
